Anixa Biosciences, Inc. (NASDAQ:ANIX – Get Free Report) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totalling 663,000 shares, a decline of 6.0% from the July 15th total of 705,300 shares. Based on an average daily volume of 88,000 shares, the days-to-cover ratio […]
HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $12.00 price target on the stock. Separately, TheStreet cut shares of Anixa Biosciences from a c- rating to a d rating in a research note […]
Anixa Biosciences, Inc. (NASDAQ:ANIX – Free Report) – Investment analysts at Chardan Capital issued their FY2023 earnings estimates for Anixa Biosciences in a research note issued to investors on Monday, July 10th. Chardan Capital analyst M. Barcus expects that the company will post earnings of ($0.45) per share for the year. Chardan Capital has a […]
Chardan Capital reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Get Rating) in a research report report published on Wednesday, MarketBeat Ratings reports. They currently have a $9.00 target price on the stock, up from their previous target price of $8.00. Chardan Capital also issued estimates for Anixa Biosciences’ FY2024 earnings at […]
Chardan Capital reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Get Rating) in a research note published on Wednesday morning, Marketbeat.com reports. They currently have a $9.00 target price on the stock, up from their previous target price of $8.00. Chardan Capital also issued estimates for Anixa Biosciences’ FY2024 earnings at $4.61 […]